@article{9034168e23b14115b934139b5b5bea99,
title = "BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology",
keywords = "Antibodies, Monoclonal/adverse effects, Antirheumatic Agents/adverse effects, Cost of Illness, Etanercept, Humans, Immunoglobulin G/adverse effects, Immunologic Factors/adverse effects, Infliximab, Receptors, Tumor Necrosis Factor/therapeutic use, Severity of Illness Index, Spondylitis, Ankylosing/diagnosis, Treatment Outcome, Tumor Necrosis Factor-alpha/antagonists \& inhibitors",
author = "A. Keat and N. Barkham and A. Bhalla and K. Gaffney and H. Marzo-Ortega and S. Paul and F. Rogers and M. Somerville and R. Sturrock and P. Wordsworth and \{BSR Standards, Guidelines and Audit Working group\}",
year = "2005",
month = jul,
doi = "10.1093/rheumatology/keh669",
language = "English",
volume = "44",
pages = "939--947",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "Oxford University Press",
number = "7",
}